약국급여관리 시장 : 세계 산업 규모, 점유율, 동향, 기회 및 예측 - 서비스별, 비즈니스 모델별, 최종사용자별, 지역별, 경쟁별 세분화(2020-2030년)

The Global Pharmacy Benefit Management Market, valued at USD 428.42 Billion in 2024, is projected to experience a CAGR of 7.21% to reach USD 650.55 Billion by 2030. Pharmacy Benefit Management (PBM) involves third-party administrators that manage prescription drug benefits for health insurers, employers, and government programs by negotiating drug prices, processing claims, and developing formularies to control costs and improve access to medications.

Key Market Drivers

The escalating costs of prescription drugs represent a fundamental driver for the Global Pharmacy Benefit Management Market, necessitating sophisticated strategies to manage pharmaceutical expenditure. As drug prices continue to climb, health insurers, employers, and government programs increasingly rely on PBMs to negotiate discounts with manufacturers, establish cost-effective formularies, and implement utilization management programs. This demand for cost containment solutions positions PBMs as critical intermediaries in the healthcare supply chain, essential for mitigating financial burdens on payers and patients.

Key Market Challenges

The persistent lack of transparency within Pharmacy Benefit Management business practices presents a substantial impediment to market growth. Opaque profit generation, particularly concerning drug pricing mechanisms and rebate structures, cultivates significant distrust among various stakeholders. This environment complicates effective oversight and prompts increased scrutiny, leading to calls for more stringent regulation.

Key Market Trends

Advanced Technology and AI Integration represents a significant trend in the Global Pharmacy Benefit Management Market, transforming operational efficiencies and enhancing service delivery. PBMs are increasingly leveraging sophisticated digital tools and artificial intelligence to automate processes, optimize formulary design, and improve patient engagement. AHIP's 2024 Consumer Experience and Digital Health Forum notably featured "AI, Data Analytics and Interoperability" as a core track, underscoring the industry's strategic emphasis on these areas for evolving healthcare delivery. This technological shift allows for more precise identification of medication non-adherence risks and streamlined administrative functions.

Key Market Players

• Optum, Inc.
• Centene Corporation (Envolve Health).
• CVS Health Corporation
• SS&C Technologies, Inc.
• Anthem, Inc..
• Elixir Rx Solutions, LLC.
• Express Scripts Holding Company
• Benecard Services, LLC.
• CaptureRx LLC

Report Scope:

In this report, the Global Pharmacy Benefit Management Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pharmacy Benefit Management Market, By Service:

• Specialty Pharmacy
• Drug Formulatory Management
• Benefit Plan Design and Consultation
• Other Services

Pharmacy Benefit Management Market, By Business Model:

• Government Health Programs
• Employer-Sponsored Programs
• Health Insurance Management

Pharmacy Benefit Management Market, By End User:

• Pharmacy Benefit Management Organization
• Mail Order Pharmacies
• Retail Pharmacies
• Other

Pharmacy Benefit Management Market, By Region:

• North America
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Pharmacy Benefit Management Market.

Available Customizations:

Global Pharmacy Benefit Management Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pharmacy Benefit Management Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Service (Specialty Pharmacy, Drug Formulatory Management, Benefit Plan Design and Consultation, Other Services)
  • 5.2.2. By Business Model (Government Health Programs, Employer-Sponsored Programs, Health Insurance Management)
  • 5.2.3. By End User (Pharmacy Benefit Management Organization, Mail Order Pharmacies, Retail Pharmacies, Other)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Pharmacy Benefit Management Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Service
  • 6.2.2. By Business Model
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Pharmacy Benefit Management Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Service
      • 6.3.1.2.2. By Business Model
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Pharmacy Benefit Management Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Service
      • 6.3.2.2.2. By Business Model
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Pharmacy Benefit Management Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Service
      • 6.3.3.2.2. By Business Model
      • 6.3.3.2.3. By End User

7. Europe Pharmacy Benefit Management Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Service
  • 7.2.2. By Business Model
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Pharmacy Benefit Management Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Service
      • 7.3.1.2.2. By Business Model
      • 7.3.1.2.3. By End User
  • 7.3.2. France Pharmacy Benefit Management Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Service
      • 7.3.2.2.2. By Business Model
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Pharmacy Benefit Management Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Service
      • 7.3.3.2.2. By Business Model
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Pharmacy Benefit Management Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Service
      • 7.3.4.2.2. By Business Model
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Pharmacy Benefit Management Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Service
      • 7.3.5.2.2. By Business Model
      • 7.3.5.2.3. By End User

8. Asia Pacific Pharmacy Benefit Management Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Service
  • 8.2.2. By Business Model
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Pharmacy Benefit Management Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Service
      • 8.3.1.2.2. By Business Model
      • 8.3.1.2.3. By End User
  • 8.3.2. India Pharmacy Benefit Management Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Service
      • 8.3.2.2.2. By Business Model
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Pharmacy Benefit Management Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Service
      • 8.3.3.2.2. By Business Model
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Pharmacy Benefit Management Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Service
      • 8.3.4.2.2. By Business Model
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Pharmacy Benefit Management Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Service
      • 8.3.5.2.2. By Business Model
      • 8.3.5.2.3. By End User

9. Middle East & Africa Pharmacy Benefit Management Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Service
  • 9.2.2. By Business Model
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Pharmacy Benefit Management Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Service
      • 9.3.1.2.2. By Business Model
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Pharmacy Benefit Management Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Service
      • 9.3.2.2.2. By Business Model
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Pharmacy Benefit Management Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Service
      • 9.3.3.2.2. By Business Model
      • 9.3.3.2.3. By End User

10. South America Pharmacy Benefit Management Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Service
  • 10.2.2. By Business Model
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Pharmacy Benefit Management Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Service
      • 10.3.1.2.2. By Business Model
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Pharmacy Benefit Management Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Service
      • 10.3.2.2.2. By Business Model
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Pharmacy Benefit Management Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Service
      • 10.3.3.2.2. By Business Model
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Pharmacy Benefit Management Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Optum, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Centene Corporation (Envolve Health).
• 15.3. CVS Health Corporation
• 15.4. SS&C Technologies, Inc.
• 15.5. Anthem, Inc..
• 15.6. Elixir Rx Solutions, LLC.
• 15.7. Express Scripts Holding Company
• 15.8. Benecard Services, LLC.
• 15.9. CaptureRx LLC

16. Strategic Recommendations

17. About Us & Disclaimer